Sundbyberg, Sweden · Founded 2014 · Privately Held (backing)
Operator of a clinical-stage biotechnology company intended to develop a new class of therapies to prevent and treat lifestyle diseases. Sigrid Therapeutics is based in Sundbyberg, Sweden and was founded in 2014. Its last reported valuation was $40.5 million in Oct 2023. It has raised $20.9 million.
Last reported valuation
$40.5M
Oct 2026
Priced at
—
Total raised
$20.9M
Last round
—
Cap table — not yet on record
Sigrid Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Sigrid Therapeutics with a free account
·The complete investor list: 16 names
·Watch Sigrid Therapeutics: the Monday email on marks, rounds and moves
